The emerging clinical significance of leptin in humans with absolute or relative leptin deficiency

Current Opinion in Endocrinology and Diabetes

Volumn 12, Issue 5, 2005, Pages 332-337

  Moschos, Stergios J ^a   Mantzoros, Christos S ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Hypothalamic amenorrhea; Immunology; Insulin resistance; Leptin; Lipodystrophy; Obesity

Indexed keywords

LEPTIN; RECOMBINANT LEPTIN;

AMENORRHEA; ANOREXIA NERVOSA; CLINICAL TRIAL; ENERGY BALANCE; GENE MUTATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPOATROPHY; METABOLIC SYNDROME X; METABOLISM; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REVIEW;

EID: 26444575752     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.med.0000177421.80858.74     Document Type: Review

References (69)

1. Heymsfield SB, Greenberg AS, Fujioka K, et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999; 282:1568-1575.
2. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science 1998; 281:1683-1686.
3. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
4. Farooqi IS, Keogh JM, Kamath S, et al. Partial leptin deficiency and human adiposity. Nature 2001; 414:34-35.
5. Ozata M, Ozdemir IC, Licinio J. Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999; 84:3686-3695.
6. Jiang Y, Wilk JB, Borecki I, et al. Common variants in the 5′ region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet 2004; 75:220-230.
7. Siegmund B, Sennello JA, Jones-Carson J, et al. Leptin receptor expression on T lymphocytes modulates chronic intestinal inflammation in mice. Gut 2004; 53:965-972.
8. Matarese G, Carrieri PB, La Cava A, et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. Proc Natl Acad Sci U S A 2005; 102:5150-5155.
9. Cammisotto PG, Gelinas Y, Deshaies Y, Bukowiecki LJ. Regulation of leptin secretion from white adipocytes by insulin, glycolytic substrates and amino acids. Am J Physiol Endocrinol Metab 2005; 1:1.
10. Considine RV. Regulation of leptin production. Rev Endocr Metab Disord 2001; 2:357-363.
11. Janeckova R. The role of leptin in human physiology and pathophysiology. Physiol Res 2001; 50:443-459.
12. Clement K, Vaisse C, Lahlou N, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392:398-401.
13. Hegyi K, Fulop K, Kovacs K, et al. Leptin-mduced signal transduction pathways. Cell Biol Int 2004; 28:159-169.
14. Chan JL, Bluher S, Yiannakouris N, et al. Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 2002; 51:2105-2112.
15. Bates SH, Stearns WH, Dundon TA, et al. STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature 2003; 421: 856-859.
16. Niswender KD, Morton GJ, Stearns WH, et al. Intracellular signalling: key enzyme in leptin-induced anorexia. Nature 2001; 413:794-795.
17. Elchebly M, Payette P, Michaliszyn E, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999; 283:1544-1548.
18. Howard JK, Cave BJ, Oksanen LJ, et al. Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3. Nat Med 2004; 10:734-738. A proof-of -principle study in rodents: negative regulators of leptin signaling may alter leptin sensitivity in rodent models of obesity.
19. Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001; 411:480-484.
20. Farooqi IS, Keogh JM, Yeo GS, et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348:1085-1095.
21. Krude H, Biebermann H, Luck W, et al. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998; 19:155-157.
22. Sahu A. Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 2004; 145:2613-2620.
23. Pinto S, Roseberry AG, Liu H, et al. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004; 304:110-115. Describes the role of leptin in regulating synaptic plasticity.
24. Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004; 304:108-110. Describes the role of leptin in regulating hypothalamic neuron axon guidance (and its differential effect in adult vs newborn mice).
25. Matochik JA, London ED, Yildiz BO, et al. Effect of leptin replacement on brain structure in genetically leptin-deficient adults. J Clin Endocrinol Metab 2005; 90:2851-2854.
26. Licinio J, Mantzoros C, Negrao AB, et al. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med 1997; 3:575-579.
27. Mantzoros CS, Flier JS, Rogol AD. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys: V: rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997; 82:1066-1070.
28. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382:250-252.
29. Chan JL, Heist K, DePaoli AM, et al. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003; 111:1409-1421.
30. Licinio J, Caglayan S, Ozata M, et al. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A 2004; 101:4531-4536. A description of the effects of long-term leptin replacement in genetically leptin-deficient adults.
31. Elefteriou F, Ahn JD, Takeda S, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005; 434:514-520.
32. Kamohara S, Burcelin R, Halaas JL, et al. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 1997; 389:374-377.
33. Haynes WG, Morgan DA, Djalali A, et al. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 1999; 33:542-547.
34. Shimabukuro M, Koyama K, Chen G, et al. Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A 1997; 94: 4637-4641.
35. Muoio DM, Dohm GL, Fiedorek FT, et al. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 1997; 46:1360-1363.
36. Dulloo AG, Stock MJ, Solinas G, et al. Leptin directly stimulates thermogenesis in skeletal muscle. FEBS Lett 2002; 515:109-113.
37. VanPatten S, Ranginani N, Shefer S, et al. Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest Liver Physiol 2001; 281:G393-G404.
38. Zhou YT, Shimabukuro M, Koyama K, et al. Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci U S A 1997; 94:6386-6390.
39. Cohen P, Miyazaki M, Socci ND, et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002; 297:240-243.
40. Fruhbeck G, Gomez-Ambrosi J, Salvador J. Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB J 2001; 15:333-340.
41. Ceddia RB, Koistinen HA, Zierath JR, Sweeney G. Analysis of paradoxical observations on the association between leptin and insulin resistance. FASEB J 2002; 16:1163-1176.
42. Franks PW, Farooqi IS, Luan J, et al. Does physical activity energy expenditure explain the between-individual variation in plasma leptin concentrations after adjusting for differences in body composition? J Clin Endocrinol Metab 2003; 88:3258-3263.
43. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002; 110:1093-1103.
44. Cochran E, Young JR, Sebring N, et al. Efficacy of recombinant methionyl human leptin therapy for the extreme insulin resistance of the Rabson-Mendenhall syndrome. J Clin Endocrinol Metab 2004; 89:1548-1554.
45. Lord GM, Matarese G, Howard JK, Lechler RI. The bioenergetics of the immune system. Science 2001; 292:855-856.
46. Chandra RK. Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice. Am J Clin Nutr 1980; 33:13-16.
47. Howard JK, Lord GM, Matarese G, et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 1999; 104:1051-1059.
48. Palacio A, Lopez M, Perez-Bravo F, et al. Leptin levels are associated with immune response in malnourished infants. J Clin Endocrinol Metab 2002; 87:3040-3046.
49. Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000; 199:15-24.
50. Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999; 194:6-11.
51. Lord GM, Matarese G, Howard JK, et al. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol 2002; 72:330-338.
52. Lord GM, Matarese G, Howard JK, et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394:897-901.
53. Mattioli B, Straface E, Quaranta MG, et al. Leptin promotes differentiation and survival of human dendritic cells and licenses them for Th1 priming. J Immunol 2005; 174:6820-6828.
54. Zhao Y, Sun R, You L, et al. Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem Biophys Res Commun 2003; 300:247-252.
55. Bruno A, Conus S, Schmid I, Simon HU. Apoptotic pathways are inhibited by leptin receptor activation in neutrophils. J Immunol 2005; 174:8090-8096.
56. Chan JL, Moschos SJ, Bullen J, et al. Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency. J Clin Endocrinol Metab 2005; 90:1625-1631. Interventional study on the role on leptin administration in regulating the immune systems of normal human subjects with leptin deficiency due to short-term starvation.
57. Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol 2005; 174:3137-3142.
58. Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112:1796-1808.
59. Chan JL, Bullen J, Stoyneva V, et al. Recombinant methionyl human leptin administration to achieve physiologic or pharmacologic leptin levels does not alter circulating inflammatory marker levels in human with leptin sufficiency of excess. J Clin Endocrinol Metab 2005; 90:1618-1624.
60. Munzberg H, Myers MG. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005; 8:566-570.
61. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-543.
62. Shimomura I, Hammer RE, Ikemoto S, et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401:73-76.
63. Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002; 346:570-578.
64. Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002; 109: 1345-1350.
65. Javor ED, Ghany MG, Cochran EK, et al. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy. Hepatology 2005; 41: 753-760.
66. Javor ED, Moran SA, Young JR, et al. Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: baseline characteristics and course during recombinant leptin therapy. J Clin Endocrinol Metab 2004; 89:3199-3207.
67. Chan JL, Mantzoros CS. Role of leptin in energy deprivation states: normal physiology and clinical implications for hypothalamic amenorrhea and anorexia nervosa. Lancet 2005; 366:74-85. Summarizes the role of leptin in leptin deficiency states in humans with a special emphasis on hypothalamic amenorrhea and anorexia nervosa.
68. Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004; 351:987-997. A proof-of-concept study in humans. Leptin replacement results in improvement of neuroendocrine function, ovulation, and menstruation in patients with hypothalamic amenorrhea.
69. Musso C, Cochran E, Javor E, et al. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients. Metabolism 2005; 54:255-263. A complementary study to the [68] demonstrating improvement of reproductive function in patients with generalized lipodystrophy, insulin resistance, and amenorrhea.